(VIANEWS) – Itau Unibanco (ITUB), Agree Realty Corporation (ADC), USA Compression Partners, LP (USAC) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Itau Unibanco (ITUB)
19.7% sales growth and 18.01% return on equity
Itaú Unibanco Holding S.A. offers a range of financial products and services to individuals and corporate customers in Brazil and internationally. The company operates through three segments: Retail Banking, Wholesale Banking, and Activities with the Market + Corporation. It offers current account; loans; credit and debit cards; investment and commercial banking services; real estate lending services; financing and investment services; economic, financial and brokerage advisory; and leasing and foreign exchange services. The company also provides property and casualty insurance products covering loss, damage, or liabilities for assets or persons, as well as life insurance products covering death and personal accident. It serves retail customers, account and non-account holders, individuals and legal entities, high income clients, microenterprises, and small companies, as well as middle-market companies and high net worth clients. The company was formerly known as Itaú Unibanco Banco Múltiplo S.A. and changed its name to Itaú Unibanco Holding S.A. in April 2009. The company was incorporated in 1924 and is headquartered in São Paulo, Brazil. Itaú Unibanco Holding S.A. operates as a subsidiary of IUPAR – Itaú Unibanco Participações S.A.
Earnings Per Share
As for profitability, Itau Unibanco has a trailing twelve months EPS of $0.66.
PE Ratio
Itau Unibanco has a trailing twelve months price to earnings ratio of 9.75. Meaning, the purchaser of the share is investing $9.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.01%.
2. Agree Realty Corporation (ADC)
14.3% sales growth and 3.38% return on equity
Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of June 30, 2020, the Company owned and operated a portfolio of 936 properties, located in 46 states and containing approximately 18.4 million square feet of gross leasable area. The common stock of Agree Realty Corporation is listed on the New York Stock Exchange under the symbol "ADC".
Earnings Per Share
As for profitability, Agree Realty Corporation has a trailing twelve months EPS of $1.7.
PE Ratio
Agree Realty Corporation has a trailing twelve months price to earnings ratio of 34.83. Meaning, the purchaser of the share is investing $34.83 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.38%.
Moving Average
Agree Realty Corporation’s worth is higher than its 50-day moving average of $56.27 and under its 200-day moving average of $63.45.
3. USA Compression Partners, LP (USAC)
13.8% sales growth and 19.97% return on equity
USA Compression Partners, LP provides natural gas compression services. The company offers compression services to oil companies and independent producers, processors, gatherers, and transporters of natural gas and crude oil, as well as operates stations. It primarily focuses on providing natural gas compression services to infrastructure applications, including centralized natural gas gathering systems and processing facilities, as well as gas lift applications for crude oil wells. As of December 31, 2022, the company had 3,716,854 horsepower in its fleet. USA Compression Partners, LP was founded in 1998 and is headquartered in Austin, Texas.
Earnings Per Share
As for profitability, USA Compression Partners, LP has a trailing twelve months EPS of $0.15.
PE Ratio
USA Compression Partners, LP has a trailing twelve months price to earnings ratio of 171.47. Meaning, the purchaser of the share is investing $171.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.97%.
Volume
Today’s last reported volume for USA Compression Partners, LP is 188204 which is 30.58% below its average volume of 271111.
Previous days news about USA Compression Partners, LP(USAC)
- According to Zacks on Tuesday, 28 November, "Investors interested in the energy sector might look at some better-ranked stocks like Liberty Energy Inc. (LBRT Quick QuoteLBRT – Free Report) , sporting a Zacks Rank #1 (Strong Buy) at present, and Oceaneering International, Inc. (OII Quick QuoteOII – Free Report) and USA Compression Partners, LP (USAC Quick QuoteUSAC – Free Report) , carrying a Zacks Rank #2 (Buy). "
- According to Zacks on Tuesday, 28 November, "Investors interested in the energysector might look at some better-ranked stocks like Liberty Energy Inc. (LBRT Quick QuoteLBRT – Free Report) , sporting a Zacks Rank #1 (Strong Buy) at present, and Oceaneering International, Inc. (OII Quick QuoteOII – Free Report) and USA Compression Partners, LP (USAC Quick QuoteUSAC – Free Report) , carrying a Zacks Rank #2 (Buy). "
4. ProLogis (PLD)
13.5% sales growth and 6.53% return on equity
Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At September 30, 2023, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (114 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 6,700 customers principally across two major categories: business-to-business and retail/online fulfillment.
Earnings Per Share
As for profitability, ProLogis has a trailing twelve months EPS of $3.14.
PE Ratio
ProLogis has a trailing twelve months price to earnings ratio of 37.37. Meaning, the purchaser of the share is investing $37.37 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.53%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
ProLogis’s EBITDA is 65.38.
Moving Average
ProLogis’s worth is above its 50-day moving average of $114.63 and below its 200-day moving average of $121.31.
Yearly Top and Bottom Value
ProLogis’s stock is valued at $117.34 at 00:22 EST, way below its 52-week high of $136.67 and way above its 52-week low of $96.64.
5. Arcos Dorados Holdings (ARCO)
8.1% sales growth and 52.84% return on equity
Arcos Dorados Holdings Inc. operates as a franchisee of McDonald's restaurants. It has the exclusive right to own, operate, and grant franchises of McDonald's restaurants in 20 countries and territories in Latin America and the Caribbean, including Argentina, Aruba, Brazil, Chile, Colombia, Costa Rica, Curaçao, Ecuador, French Guiana, Guadeloupe, Martinique, Mexico, Panama, Peru, Puerto Rico, Trinidad and Tobago, Uruguay, the U.S. Virgin Islands of St. Croix and St. Thomas, and Venezuela. As of December 31, 2019, it operated or franchised 2,293 restaurants. Arcos Dorados Holdings Inc. was founded in 2007 and is based in Montevideo, Uruguay.
Earnings Per Share
As for profitability, Arcos Dorados Holdings has a trailing twelve months EPS of $0.86.
PE Ratio
Arcos Dorados Holdings has a trailing twelve months price to earnings ratio of 13.48. Meaning, the purchaser of the share is investing $13.48 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 52.84%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 22.1%, now sitting on 4.18B for the twelve trailing months.
Sales Growth
Arcos Dorados Holdings’s sales growth is 30.8% for the present quarter and 8.1% for the next.
6. IDEXX Laboratories (IDXX)
8.1% sales growth and 92.79% return on equity
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Earnings Per Share
As for profitability, IDEXX Laboratories has a trailing twelve months EPS of $9.83.
PE Ratio
IDEXX Laboratories has a trailing twelve months price to earnings ratio of 48.93. Meaning, the purchaser of the share is investing $48.93 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 92.79%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 2.4% and 7.8%, respectively.
Volume
Today’s last reported volume for IDEXX Laboratories is 236750 which is 52.13% below its average volume of 494604.
Moving Average
IDEXX Laboratories’s value is way higher than its 50-day moving average of $435.54 and higher than its 200-day moving average of $476.95.
